Physician profile
Jonathan M Hatley
NPI 1770839979
$240.45
in general payments reported to CMS, 2019-2025
8 companies · $52.91 in 2025
The $52.91 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $14.79 · 2022: $34.07 · 2023: $44.64 · 2024: $94.04 · 2025: $52.91.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $192.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $191.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $53.08 | 2023-2024 | Infuse, Multi-Focal |
| Dompe US, INC. | $37.65 | 2022-2025 | Oxervate |
| Sun Pharmaceutical Industries INC. | $33.34 | 2025 | |
| Novartis Pharmaceuticals Corporation | $30.78 | 2021-2022 | |
| Genzyme Corporation | $28.06 | 2023 | |
| Abbvie INC. | $23.35 | 2024 | |
| Coopervision INC. | $20.43 | 2024 | Misight Contact Lens |
| Tarsus Pharmaceuticals, INC. | $13.76 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Hatley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.